|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/36 | (2006.01) |
| C07K2317/21 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/732 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 1/04 | (2006.01) | ||
| C07K 16/36 | (2013.01) | ||
| A61P 1/18 | (2006.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 13/08 | (2006.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 13/10 | (2006.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 15/08 | (2006.01) | ||
| A61P 15/08 | (2018.01) | ||
| A61P 15/14 | (2006.01) | ||
| A61P 15/14 | (2018.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Number of the document | 3159358 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16185529.1 |
| Date of filing the European patent application | 2009-12-09 | |
| (97) | Date of publication of the European application | 2017-04-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 200801744 | 2008-12-09 | DK | |
| 201335 | 2008-12-09 | US |
| (72) |
VERPLOEGEN, Sandra , NL
SATIJN, David , NL
HOET, Rene M.A. , NL
PARREN, Paul , NL
VAN DE WINKEL, Jan , NL
BREINHOLT, Vibeke Miller , DK
EHRNROOTH, Eva , DK
VINK, Tom , NL
BLEEKER, Willem Karel , NL
HOUTKAMP, Mischa , NL
OUDSHOORN, Maroeska , NL
BAADSGAARD, Ole , DK
DE JONG, Rob N. , NL
|
| (73) |
Genmab A/S ,
Carl Jacobsens Vej 30, 2500 Valby,
DK
|
| (54) | HUMAN ANTIBODIES AGAINST HUMAN TISSUE FACTOR |
| HUMAN ANTIBODIES AGAINST HUMAN TISSUE FACTOR |